8801/13381US=23 / Câncer
Lumachi F, Basso SMM, Basso U. Breast cancer recurrence: role of serum tumor markers CEA and CA 15-3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 109-15. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA RECORRENTE; PAPEL DO SORO; MARCADORES TUMORAIS; CEA; CA 15-3; ANTIGENO CARCINOEMBRIONARIO


8802/13381US=23 / Câncer
Zehentner BK. Breast cancer patients before, during or after treatment: circulating tumor cells in peripheral blood detected by multigene real-time reverse transcriptase-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 117-23. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CELULAS TUMORAIS CIRCULANTES; SANGUE PERIFERICO; REACAO MULTIGENICA EM TEMPO REAL; REACAO EM CADEIA DA POLIMERASE-TRANSCRIPTASE REVERSA


8803/13381US=28 / Urologia
Ugokwe K, Toms ST. Intracranial renal cell cancer metastasis. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 481-95. ISBN 978-1-58829-251-3.

METASTASE DE CANCER DE CELULAS RENAIS INTRACRANIANA; CARCINOMA DE CELULAS RENAIS INTRACRANIANA


8804/13381US=23 / Câncer
Feng Q, Kiviat NB. Breast cancer patients: diagnostic epigenetic markers in blood. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 125-40. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DIAGNOSTICO; MARCADORES EPIGENETICOS NO SANGUE; ANALISE DE METILACAO; METILACAO-ESPECIFICA PCR; METODO DE REACAO EM CADEIA POR POLIMERASE; ANALISE DE DADOS


8805/13381US=28 / Urologia
Davis MP. Palliation in renal cancer. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 507-28. ISBN 978-1-58829-251-3.

PALIATIVO NO CANCER RENAL; CARCINOMA DE CELULAS RENAIS


8806/13381US=23 / Câncer
Lin SR, Wang JY, Huang MY, Chen CC. Breast cancer patients: detection of circulating cancer cell-related mRNA markers with membrane array method. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 141-55. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; DETECCAO DE MARCADORES CIRCULANTES; METODO DE MATRIZ DE MRNA; METODO DE MATRIZ DE MEMBRANA; REACAO DA TRANSCRIPTASE REVERSA


8807/13381US=28 / Biol/Mol
Ribatti D, Ponzoni M. Angiogenesis in malignant and non-malignant pediatric tumors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 475-86. ISBN 978-1-58829-870-6.

ANGIOGENESE; ANGIOGENESE ANTI; TUMORES PEDIATRICOS


8808/13381US=28 / Biol/Mol
Longo R, Torino F, Gasparini G. Prognostic and predictive significance of surrogate biomarkers of angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 487-508. ISBN 978-1-58829-870-6.

PROGNOSTICO; MARCADORES PREDITIVOS; ANGIOGENESE


8809/13381US=28 / Biol/Mol
Eder JP, Zuckerman DS. Endpoints for the determination of efficacy of antiangiogenic agents in clinical trials. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 509-24. ISBN 978-1-58829-870-6.

ANGIOGENESE; ENSAIOS CLINICOS; CANCER; BIOMARCADORES


8810/13381US=28 / Biol/Mol
Clamp AR, Jayson GC. The role of imaging in the clinical development of antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 525-36. ISBN 978-1-58829-870-6.

ANGIOGENESE; ENSAIOS CLINICOS; IMAGEM; ANTIANGIOGENICS; DCE-RM; PET; CT FUNCIONAL; ULTRA-SOM


8811/13381US=23 / Câncer
Yie SM. Prediction of metastasis and recurrence of breast carcinoma: detection of survivin-expressing circulating cancer cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 157-74. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; METASTASES; CARCINOMA DA MAMA; SURVIVINA; REACAO EM CADEIA DE POLIMERASE; METODOLOGIA ELISA


8812/13381US=23 / Câncer
Xenidis N, Perrakis M, Kakolyris S, Mavroudis D, Georgoulias V. Node-negative breast cancer: predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 175-88. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOQUERATINA-19-MRNA POSITIVOS; CELULAS TUMORAIS CIRCULANTES


8813/13381US=23 / Câncer
Bianco C, Strizzi L, De Luca A, Normanno N, Salomon DS. Breast and colon carcinomas: detection with plasma CRIPTO-1. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 189-202. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMAS DE MAMA; CARCINOMA DE COLON; PLASMA CRIPTO-1; TUMORIGENESE; ELISA


8814/13381US=23 / Câncer
Baltzell K, Mills D, Ljung BM, Love S, Wrensch M. Breast cancer risk in women with abnormal cytology in nipple aspirate fluid. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 203-16. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOLOGIA ANORMAL; FLUIDO ASPIRADO; AVALIACAO DE RISCO; DUCTO MAMARIO. ANATOMIA; FLUIDO DO ASPIRADO DE MAMILO; NAF


8815/13381US=23 / Câncer
Mumenthaler SM, Yoon N, Li A, Mah V, Chang G, Nooraie F, Elshimali Y, Hanna S, Kim S, Horvath S, Apple S, Chia D, Seligson DB, Goodglick L. Tissue microarrays: construction and utilization for biomarker studies. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 217-34. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TISSUE MICROARRAYS (TMA); BIOMARCADORES; PROTOCOLOS DE MARCADORES; EXPRESSAO DE BIOMARCADORES; ANALISES DE DADOS; FERRAMENTAS ESTATISTICAS


8816/13381US=28 / Patologia
Fenoglio-Preiser CM, Noffsinger AE, Lantz P, Isaacson PG. Inflammatory bowel disease. In: ___. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 593-689. ISBN 978-0-7817-7146-7.

DOENCA INFLAMATORIA INTESTINAL; DOENCA DE CROHN; COLITE ULCEROSA; DOENCA INFLAMATORIA INTESTINAL. TRATAMENTO; DOENCA INFLAMATORIA INTESTINAL. CANCER COMPLICANDO


8817/13381US=28 / Patologia
Fenoglio-Preiser CM, Noffsinger AE, Lantz P, Isaacson PG. Polyposis and hereditary cancer syndromes. In: ___. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 691-734. ISBN 978-0-7817-7146-7.

POLIPOSE; SINDROMES HEREDITARIAS DE CANCER; SINDROMES HEREDITARIAS DE POLIPOSE; SINDROMES POLIPOSE ADENOMATOSA NAO HEREDITARIOS; SINDROMES HEREDITARIAS POLIPOSE HAMARTOMATOSAS


8818/13381US=28 / Patologia
Fenoglio-Preiser CM, Noffsinger AE, Lantz P, Isaacson PG. Epithelial neoplasms of the colon. In: ___. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 899-1035. ISBN 978-0-7817-7146-7.

NEOPLASIAS EPITELIAIS DO COLON; ADENOMAS DO COLON; CARCINOMAS DO COLON; CANCER DE COLON. PREVENCAO; ADENOMAS


8819/13381US=23 / Câncer
Kelly CMA, Ryan DN, Penny SA, Gallagher WM. Systematic validation of breast cancer biomarkers using tissue microarrays: from construction to image analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 235-50. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TISSUE MICROARRAYS (TMA); VALIDACAO SISTEMATICA DE BIOMARCADORES; CONSTRUCAO DA IMAGEM; ANALISE DE IMAGEM; PELLET CELULAR; IMUNOHISTOQUIMICA


8820/13381US=23 / Câncer
Tan PH, Tse GMK, Yip GWC, Bay BH. Phyllodes tumours of the breast: the role of immunohistochemistry in diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 251-62. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS


Primeira | Anterior | Próxima | Última